Format

Send to

Choose Destination
Curr Opin Cell Biol. 2010 Dec;22(6):816-27. doi: 10.1016/j.ceb.2010.07.013. Epub 2010 Sep 16.

Oncogene-induced senescence: the bright and dark side of the response.

Author information

1
Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece. vgorg@med.uoa.gr

Abstract

In late 1990s, it was shown that activated oncogenes are able to induce senescence. Since then large leaps in understanding this phenomenon have been achieved. There is substantial evidence supporting oncogene-induced senescence (OIS) as a potent antitumor barrier in vivo. Multiple pathways participating in cell cycle regulation, DNA damage signaling, immune response, and bioenergetics regulate the process. Despite its beneficial effects the senescent cell is thought to promote carcinogenesis and age-related disease in a nonautonomous manner. Here, we highlight the works dealing with all these aspects and discuss the studies proposing therapeutic exploitation of OIS.

PMID:
20807678
DOI:
10.1016/j.ceb.2010.07.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center